Professor Glenn Marshall is Clinical Lead for ZERO, Head of the Embryonal Cancer Research Group and Translational Research at Children’s Cancer Institute, and a Paediatric Haematologist and Oncologist at Kids Cancer Centre, Sydney Children's Hospital, Randwick.
Professor Marshall has published more than 220 research articles on biological, clinical and survivorship aspects of child cancer. His research interests include MYCN oncogene inhibitor drugs, combination anti-cancer therapy, early detection and treatment of relapsed child cancer, prevention of embryonal child cancer, and survivorship problems faced by children with chronic illness.
Find out more about Glenn on the Children's Cancer Institute website
